HEADER MEMBRANE PROTEIN 27-MAY-10 3N7S TITLE CRYSTAL STRUCTURE OF THE ECTODOMAIN COMPLEX OF THE CGRP RECEPTOR, A TITLE 2 CLASS-B GPCR, REVEALS THE SITE OF DRUG ANTAGONISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCITONIN GENE-RELATED PEPTIDE TYPE 1 RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 23-133; COMPND 5 SYNONYM: CGRP TYPE 1 RECEPTOR, CALCITONIN RECEPTOR-LIKE RECEPTOR; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: EXTRA-CELLULAR DOMAIN RESIDUES 26-117; COMPND 11 SYNONYM: CALCITONIN-RECEPTOR-LIKE RECEPTOR ACTIVITY-MODIFYING PROTEIN COMPND 12 1, CRLR ACTIVITY-MODIFYING PROTEIN 1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CALCRL, CALRL_HUMAN, CGRPR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: RAMP1, RAMP1_HUMAN; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: ROSETTA DE3; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS GPCR, CLASS B GPCR, ANTAGONIST, OLCEGEPANT, TELCAGEPANT, MIGRAINE, KEYWDS 2 MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.TER HAAR REVDAT 4 26-OCT-22 3N7S 1 COMPND REMARK SEQADV HETNAM REVDAT 3 08-NOV-17 3N7S 1 REMARK REVDAT 2 22-SEP-10 3N7S 1 JRNL REVDAT 1 15-SEP-10 3N7S 0 JRNL AUTH E.TER HAAR,C.M.KOTH,N.ABDUL-MANAN,L.SWENSON,J.T.COLL, JRNL AUTH 2 J.A.LIPPKE,C.A.LEPRE,M.GARCIA-GUZMAN,J.M.MOORE JRNL TITL CRYSTAL STRUCTURE OF THE ECTODOMAIN COMPLEX OF THE CGRP JRNL TITL 2 RECEPTOR, A CLASS-B GPCR, REVEALS THE SITE OF DRUG JRNL TITL 3 ANTAGONISM. JRNL REF STRUCTURE V. 18 1083 2010 JRNL REFN ISSN 0969-2126 JRNL PMID 20826335 JRNL DOI 10.1016/J.STR.2010.05.014 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.9.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 30514 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1509 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.17 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1615 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2460 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1537 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.83 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 78 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2900 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 85 REMARK 3 SOLVENT ATOMS : 131 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.95200 REMARK 3 B22 (A**2) : 2.73200 REMARK 3 B33 (A**2) : 6.22000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.323 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3088 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 4204 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : 986 ; 2.000 ; NULL REMARK 3 TRIGONAL CARBON PLANES : 102 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 461 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 3088 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 372 ; 5.000 ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3703 ; 4.000 ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.91 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.95 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|32 - A|57 A|61 - A|128 } REMARK 3 ORIGIN FOR THE GROUP (A): 21.1672 31.6801 68.2154 REMARK 3 T TENSOR REMARK 3 T11: 0.0691 T22: -0.1078 REMARK 3 T33: -0.0805 T12: 0.0989 REMARK 3 T13: -0.0698 T23: -0.0573 REMARK 3 L TENSOR REMARK 3 L11: 2.8727 L22: 2.0028 REMARK 3 L33: 3.6114 L12: -0.2941 REMARK 3 L13: 1.8963 L23: -0.6240 REMARK 3 S TENSOR REMARK 3 S11: -0.1564 S12: -0.1538 S13: 0.4001 REMARK 3 S21: 0.3073 S22: -0.0172 S23: -0.0324 REMARK 3 S31: -0.5358 S32: -0.0848 S33: 0.1736 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|32 - B|55 B|60 - B|129 } REMARK 3 ORIGIN FOR THE GROUP (A): 35.3148 0.2362 89.5793 REMARK 3 T TENSOR REMARK 3 T11: 0.0309 T22: -0.0688 REMARK 3 T33: -0.0961 T12: -0.0372 REMARK 3 T13: -0.0080 T23: -0.0104 REMARK 3 L TENSOR REMARK 3 L11: 1.2647 L22: 3.6935 REMARK 3 L33: 2.6231 L12: 1.0967 REMARK 3 L13: 0.4932 L23: 0.5183 REMARK 3 S TENSOR REMARK 3 S11: 0.0384 S12: -0.0151 S13: 0.0255 REMARK 3 S21: 0.0432 S22: 0.0118 S23: -0.0335 REMARK 3 S31: 0.2921 S32: -0.0431 S33: -0.0502 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|26 - C|115 } REMARK 3 ORIGIN FOR THE GROUP (A): 37.1353 18.0055 89.1422 REMARK 3 T TENSOR REMARK 3 T11: 0.0072 T22: -0.0517 REMARK 3 T33: -0.0696 T12: -0.0052 REMARK 3 T13: 0.0328 T23: 0.0044 REMARK 3 L TENSOR REMARK 3 L11: 0.6539 L22: 2.4670 REMARK 3 L33: 2.1897 L12: -0.0004 REMARK 3 L13: 0.2192 L23: -0.2683 REMARK 3 S TENSOR REMARK 3 S11: 0.0511 S12: 0.0805 S13: 0.0784 REMARK 3 S21: -0.0674 S22: -0.0481 S23: 0.0942 REMARK 3 S31: -0.1397 S32: 0.1596 S33: -0.0030 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|27 - D|111 } REMARK 3 ORIGIN FOR THE GROUP (A): 18.6699 18.5450 55.5648 REMARK 3 T TENSOR REMARK 3 T11: 0.0797 T22: -0.0908 REMARK 3 T33: -0.0847 T12: 0.0669 REMARK 3 T13: -0.0106 T23: -0.0144 REMARK 3 L TENSOR REMARK 3 L11: 3.4125 L22: 2.8741 REMARK 3 L33: 2.1473 L12: -1.6237 REMARK 3 L13: 1.0547 L23: -0.2414 REMARK 3 S TENSOR REMARK 3 S11: 0.0630 S12: 0.1305 S13: -0.2221 REMARK 3 S21: -0.2506 S22: -0.0154 S23: 0.2370 REMARK 3 S31: 0.2373 S32: -0.0294 S33: -0.0476 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3N7S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059487. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30529 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.9 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.42400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CLR/RAMP1 COMPLEX WAS MIXED WITH REMARK 280 OLCEGEPANT PRIOR TO CRYSTALLIZATION IN A 1:4 (PROTEIN:COMPOUND) REMARK 280 MOLAR RATIO. CRYSTALS WERE OBTAINED BY MIXING 0.6UL PROTEIN WITH REMARK 280 0.3UL RESERVOIR SOLUTION CONTAINING 1-1.3M AMMONIUM SULFATE, 6-8% REMARK 280 DIOXANE, 60-80MM MES PH 6.5, 0.4 M POTASSIUM THIOCYANATE. THE REMARK 280 CRYSTALS WERE TRANSFERRED TO 2.1M NAMALONATE (PH 7.0) PRIOR TO REMARK 280 FREEZING IN LIQUID NITROGEN, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.57900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.57900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 36.65250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.56550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 36.65250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.56550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 68.57900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 36.65250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.56550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 68.57900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 36.65250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.56550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 218 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 19 REMARK 465 SER A 20 REMARK 465 HIS A 21 REMARK 465 MET A 22 REMARK 465 GLU A 23 REMARK 465 LEU A 24 REMARK 465 GLU A 25 REMARK 465 GLU A 26 REMARK 465 SER A 27 REMARK 465 PRO A 28 REMARK 465 GLU A 29 REMARK 465 ASP A 30 REMARK 465 SER A 31 REMARK 465 GLN A 58 REMARK 465 GLN A 59 REMARK 465 ALA A 60 REMARK 465 VAL A 129 REMARK 465 ASN A 130 REMARK 465 THR A 131 REMARK 465 HIS A 132 REMARK 465 GLU A 133 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 HIS B 21 REMARK 465 MET B 22 REMARK 465 GLU B 23 REMARK 465 LEU B 24 REMARK 465 GLU B 25 REMARK 465 GLU B 26 REMARK 465 SER B 27 REMARK 465 PRO B 28 REMARK 465 GLU B 29 REMARK 465 ASP B 30 REMARK 465 SER B 31 REMARK 465 PRO B 56 REMARK 465 ILE B 57 REMARK 465 GLN B 58 REMARK 465 GLN B 59 REMARK 465 THR B 131 REMARK 465 HIS B 132 REMARK 465 GLU B 133 REMARK 465 GLY C 22 REMARK 465 SER C 23 REMARK 465 HIS C 24 REMARK 465 MET C 25 REMARK 465 SER C 117 REMARK 465 GLY D 22 REMARK 465 SER D 23 REMARK 465 HIS D 24 REMARK 465 MET D 25 REMARK 465 ALA D 26 REMARK 465 VAL D 111 REMARK 465 ARG D 112 REMARK 465 ASP D 113 REMARK 465 PRO D 114 REMARK 465 PRO D 115 REMARK 465 GLY D 116 REMARK 465 SER D 117 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 32 CB CG1 CG2 CD1 REMARK 470 LEU A 34 CG CD1 CD2 REMARK 470 LYS A 40 CG CD CE NZ REMARK 470 GLU A 61 CB CG CD OE1 OE2 REMARK 470 VAL A 63 CG1 CG2 REMARK 470 VAL A 78 CG1 CG2 REMARK 470 ASP A 96 CB CG OD1 OD2 REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 ASN A 118 CG OD1 ND2 REMARK 470 ILE B 32 CG1 CG2 CD1 REMARK 470 GLN B 33 CG CD OE1 NE2 REMARK 470 ALA B 60 CB REMARK 470 GLU B 61 CB CG CD OE1 OE2 REMARK 470 VAL B 129 CB CG1 CG2 REMARK 470 ASN B 130 CB CG OD1 ND2 REMARK 470 ILE C 106 CG1 CG2 CD1 REMARK 470 ARG C 109 CG CD NE CZ NH1 NH2 REMARK 470 ALA C 110 CB REMARK 470 GLU D 29 CG CD OE1 OE2 REMARK 470 ARG D 64 CG CD NE CZ NH1 NH2 REMARK 470 SER D 107 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG D 37 O HOH D 205 1.90 REMARK 500 NE1 TRP B 72 O HOH B 238 2.16 REMARK 500 NH2 ARG B 38 OD2 ASP C 71 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA C 110 N - CA - C ANGL. DEV. = 16.2 DEGREES REMARK 500 PRO C 115 CB - CA - C ANGL. DEV. = 15.0 DEGREES REMARK 500 GLY C 116 N - CA - C ANGL. DEV. = -17.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 67 139.17 -39.24 REMARK 500 TRP A 72 -37.13 -133.57 REMARK 500 TRP B 72 -41.59 -133.61 REMARK 500 ASN B 128 -70.88 -101.88 REMARK 500 VAL B 129 35.86 71.02 REMARK 500 GLN C 28 87.20 -69.43 REMARK 500 ALA C 110 56.32 -147.06 REMARK 500 VAL C 111 -70.06 -120.07 REMARK 500 PRO D 85 -163.08 -79.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN B 128 VAL B 129 140.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3N6 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3N7 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3N7P RELATED DB: PDB REMARK 900 RELATED ID: 3N7R RELATED DB: PDB DBREF 3N7S A 23 133 UNP Q16602 CALRL_HUMAN 23 133 DBREF 3N7S B 23 133 UNP Q16602 CALRL_HUMAN 23 133 DBREF 3N7S C 26 117 UNP O60894 RAMP1_HUMAN 26 117 DBREF 3N7S D 26 117 UNP O60894 RAMP1_HUMAN 26 117 SEQADV 3N7S GLY A 19 UNP Q16602 EXPRESSION TAG SEQADV 3N7S SER A 20 UNP Q16602 EXPRESSION TAG SEQADV 3N7S HIS A 21 UNP Q16602 EXPRESSION TAG SEQADV 3N7S MET A 22 UNP Q16602 EXPRESSION TAG SEQADV 3N7S GLY B 19 UNP Q16602 EXPRESSION TAG SEQADV 3N7S SER B 20 UNP Q16602 EXPRESSION TAG SEQADV 3N7S HIS B 21 UNP Q16602 EXPRESSION TAG SEQADV 3N7S MET B 22 UNP Q16602 EXPRESSION TAG SEQADV 3N7S GLY C 22 UNP O60894 EXPRESSION TAG SEQADV 3N7S SER C 23 UNP O60894 EXPRESSION TAG SEQADV 3N7S HIS C 24 UNP O60894 EXPRESSION TAG SEQADV 3N7S MET C 25 UNP O60894 EXPRESSION TAG SEQADV 3N7S GLY D 22 UNP O60894 EXPRESSION TAG SEQADV 3N7S SER D 23 UNP O60894 EXPRESSION TAG SEQADV 3N7S HIS D 24 UNP O60894 EXPRESSION TAG SEQADV 3N7S MET D 25 UNP O60894 EXPRESSION TAG SEQRES 1 A 115 GLY SER HIS MET GLU LEU GLU GLU SER PRO GLU ASP SER SEQRES 2 A 115 ILE GLN LEU GLY VAL THR ARG ASN LYS ILE MET THR ALA SEQRES 3 A 115 GLN TYR GLU CYS TYR GLN LYS ILE MET GLN ASP PRO ILE SEQRES 4 A 115 GLN GLN ALA GLU GLY VAL TYR CYS ASN ARG THR TRP ASP SEQRES 5 A 115 GLY TRP LEU CYS TRP ASN ASP VAL ALA ALA GLY THR GLU SEQRES 6 A 115 SER MET GLN LEU CYS PRO ASP TYR PHE GLN ASP PHE ASP SEQRES 7 A 115 PRO SER GLU LYS VAL THR LYS ILE CYS ASP GLN ASP GLY SEQRES 8 A 115 ASN TRP PHE ARG HIS PRO ALA SER ASN ARG THR TRP THR SEQRES 9 A 115 ASN TYR THR GLN CYS ASN VAL ASN THR HIS GLU SEQRES 1 B 115 GLY SER HIS MET GLU LEU GLU GLU SER PRO GLU ASP SER SEQRES 2 B 115 ILE GLN LEU GLY VAL THR ARG ASN LYS ILE MET THR ALA SEQRES 3 B 115 GLN TYR GLU CYS TYR GLN LYS ILE MET GLN ASP PRO ILE SEQRES 4 B 115 GLN GLN ALA GLU GLY VAL TYR CYS ASN ARG THR TRP ASP SEQRES 5 B 115 GLY TRP LEU CYS TRP ASN ASP VAL ALA ALA GLY THR GLU SEQRES 6 B 115 SER MET GLN LEU CYS PRO ASP TYR PHE GLN ASP PHE ASP SEQRES 7 B 115 PRO SER GLU LYS VAL THR LYS ILE CYS ASP GLN ASP GLY SEQRES 8 B 115 ASN TRP PHE ARG HIS PRO ALA SER ASN ARG THR TRP THR SEQRES 9 B 115 ASN TYR THR GLN CYS ASN VAL ASN THR HIS GLU SEQRES 1 C 96 GLY SER HIS MET ALA CYS GLN GLU ALA ASN TYR GLY ALA SEQRES 2 C 96 LEU LEU ARG GLU LEU CYS LEU THR GLN PHE GLN VAL ASP SEQRES 3 C 96 MET GLU ALA VAL GLY GLU THR LEU TRP CYS ASP TRP GLY SEQRES 4 C 96 ARG THR ILE ARG SER TYR ARG GLU LEU ALA ASP CYS THR SEQRES 5 C 96 TRP HIS MET ALA GLU LYS LEU GLY CYS PHE TRP PRO ASN SEQRES 6 C 96 ALA GLU VAL ASP ARG PHE PHE LEU ALA VAL HIS GLY ARG SEQRES 7 C 96 TYR PHE ARG SER CYS PRO ILE SER GLY ARG ALA VAL ARG SEQRES 8 C 96 ASP PRO PRO GLY SER SEQRES 1 D 96 GLY SER HIS MET ALA CYS GLN GLU ALA ASN TYR GLY ALA SEQRES 2 D 96 LEU LEU ARG GLU LEU CYS LEU THR GLN PHE GLN VAL ASP SEQRES 3 D 96 MET GLU ALA VAL GLY GLU THR LEU TRP CYS ASP TRP GLY SEQRES 4 D 96 ARG THR ILE ARG SER TYR ARG GLU LEU ALA ASP CYS THR SEQRES 5 D 96 TRP HIS MET ALA GLU LYS LEU GLY CYS PHE TRP PRO ASN SEQRES 6 D 96 ALA GLU VAL ASP ARG PHE PHE LEU ALA VAL HIS GLY ARG SEQRES 7 D 96 TYR PHE ARG SER CYS PRO ILE SER GLY ARG ALA VAL ARG SEQRES 8 D 96 ASP PRO PRO GLY SER HET 3N6 A 1 54 HET 3N7 B 1 26 HET SO4 C 1 5 HETNAM 3N6 N-{(1S)-5-AMINO-1-[(4-PYRIDIN-4-YLPIPERAZIN-1-YL) HETNAM 2 3N6 CARBONYL]PENTYL}-3,5-DIBROMO-NALPHA-{[4-(2-OXO-1,4- HETNAM 3 3N6 DIHYDROQUINAZOLIN-3 (2H)-YL)PIPERIDIN-1-YL]CARBONYL}- HETNAM 4 3N6 D-TYROSINAMIDE HETNAM 3N7 N~4~-(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)-N~2~-1H-INDAZOL-5- HETNAM 2 3N7 YL-6-METHYLPYRIMIDINE-2,4-DIAMINE HETNAM SO4 SULFATE ION HETSYN 3N6 OLCEGEPANT FORMUL 5 3N6 C38 H47 BR2 N9 O5 FORMUL 6 3N7 C18 H18 N8 FORMUL 7 SO4 O4 S 2- FORMUL 8 HOH *131(H2 O) HELIX 1 1 ILE A 32 MET A 53 1 22 HELIX 2 2 TYR A 124 ASN A 128 5 5 HELIX 3 3 GLY B 35 GLN B 54 1 20 HELIX 4 4 GLN C 28 CYS C 40 1 13 HELIX 5 5 CYS C 40 GLY C 52 1 13 HELIX 6 6 GLU C 53 TRP C 56 5 4 HELIX 7 7 ASP C 58 GLY C 81 1 24 HELIX 8 8 ASN C 86 PHE C 101 1 16 HELIX 9 9 GLN D 28 LEU D 39 1 12 HELIX 10 10 LEU D 39 GLY D 52 1 14 HELIX 11 11 GLU D 53 TRP D 56 5 4 HELIX 12 12 ASP D 58 GLY D 81 1 24 HELIX 13 13 ASN D 86 PHE D 101 1 16 SHEET 1 A 2 TYR A 64 CYS A 65 0 SHEET 2 A 2 VAL A 78 ALA A 79 -1 O VAL A 78 N CYS A 65 SHEET 1 B 2 THR A 68 TRP A 69 0 SHEET 2 B 2 CYS A 74 TRP A 75 -1 O TRP A 75 N THR A 68 SHEET 1 C 2 GLU A 83 LEU A 87 0 SHEET 2 C 2 LYS A 100 ILE A 104 -1 O VAL A 101 N GLN A 86 SHEET 1 D 2 TYR B 64 CYS B 65 0 SHEET 2 D 2 VAL B 78 ALA B 79 -1 O VAL B 78 N CYS B 65 SHEET 1 E 2 THR B 68 TRP B 69 0 SHEET 2 E 2 CYS B 74 TRP B 75 -1 O TRP B 75 N THR B 68 SHEET 1 F 2 GLU B 83 LEU B 87 0 SHEET 2 F 2 LYS B 100 ILE B 104 -1 O VAL B 101 N GLN B 86 SSBOND 1 CYS A 48 CYS A 74 1555 1555 2.04 SSBOND 2 CYS A 65 CYS A 105 1555 1555 2.03 SSBOND 3 CYS A 88 CYS A 127 1555 1555 2.04 SSBOND 4 CYS B 48 CYS B 74 1555 1555 2.05 SSBOND 5 CYS B 65 CYS B 105 1555 1555 2.03 SSBOND 6 CYS B 88 CYS B 127 1555 1555 2.04 SSBOND 7 CYS C 27 CYS C 82 1555 1555 2.04 SSBOND 8 CYS C 40 CYS C 72 1555 1555 2.05 SSBOND 9 CYS C 57 CYS C 104 1555 1555 2.04 SSBOND 10 CYS D 27 CYS D 82 1555 1555 2.03 SSBOND 11 CYS D 40 CYS D 72 1555 1555 2.05 SSBOND 12 CYS D 57 CYS D 104 1555 1555 2.04 CISPEP 1 TRP C 84 PRO C 85 0 -5.02 CISPEP 2 PRO C 115 GLY C 116 0 -1.94 CISPEP 3 TRP D 84 PRO D 85 0 -3.49 SITE 1 AC1 20 ASP A 70 GLY A 71 TRP A 72 PHE A 92 SITE 2 AC1 20 ASP A 94 ARG A 119 TRP A 121 THR A 122 SITE 3 AC1 20 TYR A 124 HOH A 201 HOH A 202 HOH A 204 SITE 4 AC1 20 ASN C 31 LEU C 39 LYS C 79 LEU C 80 SITE 5 AC1 20 ALA D 70 ASP D 71 TRP D 74 TRP D 84 SITE 1 AC2 15 LYS B 40 ALA B 44 GLU B 47 CYS B 48 SITE 2 AC2 15 LYS B 51 CYS B 74 TRP B 75 ASN B 76 SITE 3 AC2 15 SER B 84 MET B 85 GLN B 86 ASP B 90 SITE 4 AC2 15 HOH B 208 HOH B 216 HOH B 219 SITE 1 AC3 6 MET B 42 ALA C 70 ASP C 71 TRP C 74 SITE 2 AC3 6 TRP C 84 VAL C 111 CRYST1 73.305 119.131 137.158 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013642 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008394 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007291 0.00000